Multiplex GPCR assay in reverse transfection cell microarrays

• Published in: Journal of biomolecular screening Vol. 9; no. 3; pp. 196 - 207
• Main Authors: Mishina, Yuji M, Wilson, Christopher J, Bruett, Linda, Smith, Jesse J, Stoop-Myer, Chatanika, Jong, Sena, Amaral, Lizabeth P, Pedersen, Robin, Lyman, Susan K, Myer, Vic E, Kreider, Brent L, Thompson, Craig M
• Format: Journal Article
• Language: English
• Published: United States 01.04.2004
• Subjects: Dose-Response Relationship, Drug; Drug Evaluation, Preclinical - instrumentation; Drug Evaluation, Preclinical - methods; GTP-Binding Proteins - genetics; Humans; Ligands; Protein Array Analysis - instrumentation; Protein Array Analysis - methods; Receptors, G-Protein-Coupled - agonists; Receptors, G-Protein-Coupled - analysis; Receptors, G-Protein-Coupled - antagonists & inhibitors; Receptors, G-Protein-Coupled - genetics; Transfection - methods
• ISSN: 1087-0571; 2472-5552; 1552-454X
• DOI: 10.1177/1087057103261880

G protein-coupled receptors (GPCRs) are a superfamily of proteins that include some of the most important drug targets in the pharmaceutical industry. Despite the success of this group of drugs, there remains a need to identify GPCR-targeted drugs with greater selectivity, to develop screening assays for validated targets, and to identify ligands for orphan receptors. To address these challenges, the authors have created a multiplexed GPCR assay that measures greater than 3000 receptor: ligand interactions in a single microplate. The multiplexed assay is generated by combining reverse transfection in a 96-well plate format with a calcium flux readout. This assay quantitatively measures receptor activation and inhibition and permits the determination of compound potency and selectivity for entire families of GPCRs in parallel. To expand the number of GPCR targets that may be screened in this system, receptors are cotransfected with plasmids encoding a promiscuous G protein, permitting the analysis of receptors that do not normally mobilize intracellular calcium upon activation. The authors demonstrate the utility of reverse transfection cell microarrays to GPCR-targeted drug discovery with examples of ligand selectivity screening against a panel of GPCRs as well as dose-dependent titrations of selected agonists and antagonists.